mXELOXIRI versus FOLFOX/FOLFIRI Combined With Molecular Targeting Drug in the First-line Treatment of Patients With Initially Unresectable Metastatic Colorectal Cancer: A Phase II, Randomized, Prospective Controlled Trial
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: Experimental group:mXELOXIRI;Control group:FOLFOX/FOLFIRI Combined With Molecular Targeting Drug Primary outcome(s): Objective response rate Study Design: Parallel
创建时间：
2019-11-15
